Additional Collaboration Targets Sample Clauses

Additional Collaboration Targets. (a) Jazz shall nominate one additional Target as a Collaboration Target by delivering a Collaboration Target Designation Notice within [***] of the Effective Date. If, (i) in the case of a nomination occurring within one year after the Effective Date, such nominated Target is neither a Pre-Existing Excluded Target nor qualifies for clause (b) of the definition of “Excluded Target”, or (ii) in the case of any other nomination, such nominated Target is a Designatable Target, in each case ((i) and (ii)), Codiak shall so notify Jazz and such nominated Target shall automatically become an additional Collaboration Target (an “Additional Collaboration Target”). If (x) in the case of a nomination occurring within [***] after the Effective Date, such nominated Target is either a Pre-Existing Excluded Target or qualifies for clause (b) of the definition of “Excluded Target”, or (y) in the case of any other nomination, such nominated Target is an Excluded Target other than any Excluded Target listed on the most-recently-provided list of Excluded Targets provided by Codiak to Jazz pursuant to Section 2.5, then, in each case ((x) and (y)), Codiak shall promptly notify Jazz, and Jazz shall have the right to repeat the nomination process provided by this Section 2.5.1(a) within [***] after Jazz’s receipt of such notification, at which point in time such right shall expire if not already exercised, provided that Jazz shall have the right to repeat such nomination process until a Target is successfully nominated. (b) Jazz may nominate [***] replacement Target as a Collaboration Target if [***] Collaboration Targets fail prior to IND Acceptance, by delivering a Collaboration Target Designation Notice within [***] following the failure of the second of such two Collaboration Targets. If such nominated Target is a Designatable Target, Codiak shall so notify Jazz and such nominated Target shall automatically become a replacement Collaboration Target (a “Replacement Target”). If such nominated Target is an Excluded Target other than any Excluded Target listed on the most-recently-provided list of Excluded Targets provided by Codiak to Jazz pursuant to Section 2.5, then Codiak shall promptly notify Jazz, and Jazz shall have the right to repeat the nomination process provided by this Section 2.5.1(b) within [***] after Jazz’s receipt of such notification, at which point in time such right shall expire if not already exercised, provided that Jazz shall have the right to repeat suc...

Additional Collaboration Targets. Northwest shall have the right to offer additional Antigens to the Collaboration as Collaboration Targets, by providing Medarex with any and all Antigen Evaluation Materials with respect to such Antigen and such other information and data as Medarex may request. In the event that the Parties agree to accept any such additional Antigen into the Collaboration, the Parties shall use good faith efforts to agree on a written description of such Antigen, and Appendix C-2 shall be automatically amended to include such Antigen and such description.

Additional Collaboration Targets. Licensee may add one (1) or more Collaboration Targets in addition to the three (3) initial Collaboration Targets after the selection of the three (3) initial Collaboration Targets pursuant to the terms set forth in Section 8.1(a); provided however, that any such addition must be mutually agreed in writing between the Parties.

Additional Collaboration Targets. Within *** from the Effective Date, BI may submit in writing to MacroGenics additional Dual Target Combinations (which must be accompanied by the Entrez Gene ID, HUGO or official symbol and any common synonyms, if available, for each Target included in such Dual Target Combination) which BI in good faith wishes to include as Collaboration Targets; provided that in no event shall there be more than *** Collaboration Targets at any time during the Research Term. For purposes of clarity, BI shall have the right to substitute Collaboration Targets in accordance with Section 3.2(d). MacroGenics shall, subject to Section 3.2(c), provide BI written notice of whether any such additional Dual Target Combinations shall be included as Collaboration Targets within *** Business Days after receipt of notice of such additional Dual Target Combinations.

Additional Collaboration Targets. In addition to Company’s substitution rights under Section 2.3.1, during the Collaboration Research Term, the Parties may mutually agree to add any Reserved Target or other Target as a Collaboration Target under this Agreement, thereby increasing the total number of Collaboration Targets under this Agreement, provided that Vertex shall make a payment to Company in the amount of [***] for each additional Target so added as a Collaboration Target under this Agreement. In such event, (a) such addition, including the identity of the additional Target, shall be recorded in a written acknowledgement duly executed by both Parties, and the date on which such Target is so designated mutually by the Parties shall be the “Addition Date”; (b) as of the Addition Date, such additional Target shall automatically be deemed to be a Collaboration Target under this Agreement with no further action by the Parties; (c) as of the Addition Date, if the added Collaboration Target was a Reserved Target, such added Collaboration Target shall no longer be a Reserved Target under this Agreement; (d) Company shall promptly prepare a Research Plan or Research Outline for the added Collaboration Target meeting the criteria set forth in Section 2.2.1 and provide the Research Plan or Research Outline to the JAC for review and discussion; and (e) if the added Collaboration Target was not a Reserved Target, the Parties will discuss and mutually agree upon the Exclusive Area for such Collaboration Target, which Exclusive Area shall be recorded in a written acknowledgement duly executed by both Parties.

Additional Collaboration Targets. During the period which commences on the Effective Date and ends on [**], Novartis may propose additional Targets for inclusion in this Agreement as Collaboration Targets (each, a “Proposed Additional Target”) by providing written notice to the Gatekeeper of the identity of the Proposed Additional Target. If the Gatekeeper informs Novartis that such Proposed Additional Target is not on the list of Unavailable Targets and ▇▇▇▇▇▇▇▇▇▇▇ does not reasonably reject to the selection of such Proposed Additional Target as an Additional Collaboration Target, within [**] from the date of receipt of the Gatekeeper Notice, the Parties shall meet to discuss the timing, roles and responsibilities of each Party, economics, and the Project Plan of such Proposed Additional Target. From and after the date on which the Project Plan for the Proposed Additional Target is approved by the JSC, such Proposed Additional Target shall become a Collaboration Target included in this Agreement (each, an “Additional Collaboration Target”). Any replacement of an Additional Collaboration Target shall be made in accordance with the procedure and requirements set out in Section 3.3(b) (Other Replacement) and Section 3.3(c) (Target Replacement Procedure). Upon delivery by Novartis to Schrödinger of a Suitability Analysis Notice with respect to any Proposed Additional Target, and until the earlier of the date that (A) such Proposed Additional Target becomes an Additional Collaboration Target or (B) either Party notifies the other of its final determination not to effect the addition of such Proposed Additional Target as an Additional Collaboration Target, such Proposed Additional Target will be deemed a Collaboration Target for purposes of Article 11 (Exclusivity).

Additional Collaboration Targets. At any time after there are [***] Collaboration Targets designated pursuant to Section 2.2(a), BMS may, from time to time, request to designate additional targets as Collaboration Targets. Upon such request, the Parties will discuss the terms under which such targets would become Collaboration Targets with such terms subject to each Party's consent in its sole discretion. For clarity, Tranzyme shall have no obligation to accept any Additional Collaboration Targets; provided that Tranzyme shall include any target designated by BMS pursuant to Section 2.2(f) under the terms thereof and subject to the gatekeeping procedure of Section 2.2(c). PORTIONS OF THIS EXHIBIT WERE OMITTED AND HAVE BEEN FILED SEPARATELY WITH THE SECRETARY OF THE COMMISSION PURSUANT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT UNDER RULE 406 OF THE SECURITIES ACT; [***] DENOTES OMISSIONS.

Additional Collaboration Targets. As described in Section 3.4.1 (Collaboration Targets), GNE shall have the right to designate up to [***] Additional Collaboration Targets in addition to the [***] Initial Collaboration Targets. For each of these Additional Collaboration Targets, GNE shall pay Adaptimmune a non-refundable, non-creditable, payment of [***] (each an “Additional Collaboration Target Designation Fee”) in consideration for the grant of the rights for such Additional Collaboration Targets, such payment to be made by GNE to Adaptimmune within [***] days after receipt of invoice (which shall not be given to GNE prior to when the nominated Target is deemed an Additional Collaboration Target in accordance with Section 3.6 (Nomination)) from Adaptimmune for such Additional Collaboration Target Designation Fee. For clarity, no Additional Collaboration Target Designation Fee shall be due if any Collaboration Target is substituted in accordance with Section 3.4.2 (Collaboration Target Substitution). ​

Additional Collaboration Targets. During the Project Research Term for each Project, the Parties shall prepare and collaborate to conduct such Project to identify Collaboration Compounds for the applicable Collaboration Target (or [**]) in accordance with one or more written plans for such Project (each, a “Project Plan”). Each Project Plan shall detail (i) the allocation of responsibilities and activities between Schrӧdinger and Novartis with respect to carrying out the Project, including the testing and iterative optimization process and compound synthesis; (ii) the DC Criteria and requirements for the Achievement of the DC Criteria; (iii) any additional Discovery Milestone Criteria, as applicable; (iv) an estimated timeline for performance of such activities and (v) the [**] for such Project Plan. Subject to Section 3.3(e) (Additional [**]), each Party shall initiate its activities under each Project Plan promptly following the adoption of such Project Plan. Each [**] selected as the subject of a Project as of the Effective Date or pursuant to Section 3.3(e) (Additional [**]) shall be the subject of a separate Project Plan.